参考文献/References:
[1] World Health Organization.(2020). Clinicalmanagement of severe acute respiratory infectionwhen novel coronavirus (nCoV) infection is suspected:interim guidance[OL]. https://www.who.int/iris/handle/10665/330854.
[2] ZHONG N S , ZHENG B J , LI Y M , et al. Epidemiology and cause of severe acute respiratory syndrome(SARS) in Guangdong, People’s Republic of China, inFebruary, 2003[J]. Lancet,2003, 362(9393):1353-1358.
[3] WONG Gary, LIU Wenjun, LIU Yingxia, et al. MERS,SARS, and Ebola: the role of super-spreaders in infectious disease[J]. Cell Host Microbe 2015,18(4):398-401.
[4] ZHU Na , ZHANG Dingyu , WANG Wenling , et al.A Novel Coronavirus from Patients with Pneumoniain China, 2019[J]. New England Journal of Medicine,2020, 382(8):727-733.
[5] LIU Rui，HAN Huan，LIU Fang，et al. Positiverate of RT-PCR detection of SARS-CoV-2 infection in4 880 cases from one hospital in Wuhan, China, fromJan to Feb 2020[J]. Clin Chim Acta, 2020,505:172-175.
[6] WANG Wenling, XU Yanli, GAO Ruqin, et al. Detection of SARS-CoV-2 in different types of clinical specimens[J]. the Journal of the American Medical, 2020,323(18):1843-1844.
[7] 中华人民共和国国家卫生健康委员会（国卫办医函 184）：关于印发新型冠状病毒感染的肺炎诊疗方案（试行第七版）的通知 [EB/OL](2020-03-04).http:/www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml. National Health Commission of the People’s Republicof China, Medical Letter of the state Health office
[2020]NO.184:Notification on the issuance ofCOVID-19 medical programctrial seventh edition[EB/OL] (2020-03-04). http:/www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
[8] NIE Jianhui, LI Qianqian, WU Jiajing, et al. Establishment and validation of a pseudovirus neutralizationassay for SARS-CoV-2[J]. Emerging Microbes and Infections, 2020, 9(1):680-686.
[9] LI Qun, GUAN Xuhua, WU Peng, et al. Earlytransmission dynamics in Wuhan, China, of NovelCoronavirus-infected pneumonia[J]. The New EnglandJournal of Medicine, 2020,382(13):1199-1207.
[10] LI Zhengtu , YI Yongxiang, LUO Xiaomei, et al. Development and clinical application of a rapid IgMIgG combined antibody test for SARS-CoV-2 infection diagnosis[J]. Journal of Medical Virology, 2020,92(9):1518-1524.
[11] TO K W , TSANG T Y , LEUNG W S, et al. Temporalprofiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infectionby SARS-CoV-2: an observational cohort study[J]. TheLancet Infectious Diseases, 2020, 20(5):565-574.
[12] XU D , ZHANG Z , JIN L , et al. Persistent shedding ofviable SARS-CoV in urine and stool of SARS patientsduring the convalescent phase[J]. European Journal ofClinical Microbiology and Infectious Diseases, 2005,24(3):165-171.
[13] 张稳健 , 吕欣 , 黄驰 , 等 . 胶体金免疫层析法检测新型冠状病毒 IgM/IgG 抗体的临床评价与应用 [J]. 病毒学报 ,2020,36(3):348-354. ZHANG Wenjian, L? Xin, HUANG Chi, et al. Clinicalevaluation and application of detection of IgM and IgGantibodies against-SARS-CoV-2 using a colloidal goldimmunochromatography assay[J]. Chinese Journal ofVirology,2020,36(3):348-354.
[14] 童伟 , 陈登奕 , 陈俊文 , 等 .2019-nCoV 总抗体两种免疫学检测方法的应用评价 [J]. 现代检验医学杂志 ,2020,35(2):80-82. TONG Wei, CHEN Dengyi, CHEN Junwen, et al.Application evaluation of two immunological detectionmethods of 2019-NCoV specific antibodies[J]. Journal of Modern Laboratory Medicine,2020,35(2):80-82.
[15] GUO Li，REN Lili，YANG Siyuan，et al. Profilingearly humoral response to diagnose novel coronavirusdisease (COVID-19)[J].Clinical Infectious Diseases,2020,71(15):778-785.
[16] YAN Ying, CHANG Le, WANG Lunan. Laboratorytesting of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 (2019‐nCoV): Current status, challenges,and countermeasures[J]. Reviews in Medical Virology,2020, 30(3):e2106.
[17] 李雪寒 , 赵 瑾 , 潘运宝 , 等 . 新型冠状病毒特异性抗体检测现状及应用思考 [J]. 中华检验医学杂志 ,2020,43(7):691-696. LI Xuehan, ZHAO Jin, PAN Yunbao, et al. Statusquoand review of clinical application of antibody detectionfor 2019-nCoV[J]. Chinese Journal of LaboratoryMedicine,2020,43(7):691-696.
[18] HANSON K E , CALIENDO A M , ARIAS C A , etal. Infectious diseases society of america guidelineson the diagnosis of COVID-19:serologic testing[J].Clinical Infectious Diseases. http://doi.org/10.1093/cid/ciab048.2020.
[19] POST N，EDDY D，HUNTLEY, C，et al. Antibodyresponse to SARS-CoV-2 infection in humans:A systematic review[J]. PLoS One. 2020,15(12):e0244126.
[20] BOND K，NICHOLSON S，LIM S M，et al. Evaluation of serological tests for SARS-CoV-2: Implicationsfor serology testing in a low-prevalence setting[J].TheJournal of Infectious Diseases. 2020,222(8):1280-1288.
[21] World Health Orgnaization. Laboratory testing for 2019novel coronavirus (2019-nCoV) in suspected humancases interim guidance[S].Geneva: World HealthOrganization, 2020.
[22] NG K W，FAULKNER N，CORNISH G H，et al. Preexisting and de novo humoral immunity to SARSCoV-2 in humans[J].Science.2020,370(6522): 1339-1343.
[23] WANG Yunshan，SHEN Hong，SUN Shanhui，et al. Analysis of false positive associated with antibody tests for SARS-CoV in SLE patients[J].ActaBiologiae Experimentalis Sinica.2003,36(4):314-317.
[24] SHAO Xiuping, GUO Xiaojie, ESPER F, et al.Seroepidemiology of group I human coronaviruses inchildren[J]. Journal of Clinical Virology, 2007, 40 (3):207-213.
[25] CHAN K H , CHAN J F W , TSE H , et al. Cross-reactive antibodies in convalescent SARS patients’ seraagainst the emerging novel human coronavirus EMC(2012) by both immunofluorescent and neutralizingantibody tests[J]. Journal of Infection, 2013, 67(2):130-140.
[26] DIJKMAN R , JEBBINK M F , GAUNT E , et al. Thedominance of human coronavirus OC43 and NL63infections in infants[J]. Journal of Clinical Virology,2012, 53(2):135-139.
[27] SUN Z F , MENG X J . Antigenic cross-reactivitybetween the nucleocapsid protein of severe acuterespiratory syndrome (SARS) coronavirus andpolyclonal antisera of antigenic group I animalcoronaviruses: implication for SARS diagnosis[J].Journal of Clinical Microbiology, 2004, 42(5):2351-2352.
[28] WOO P C，LAU S K，WONG B H，et al. False-positive results in a recombinant severe acute respiratorysyndrome-associated coronavirus ( SARS-CoV) nucleocapsid enzymelinked immunosorbent assay dueto HCoV-OC43 and HCoV-229E rectified by westernblotting with recombinant SARS-CoV spike polypeptide[J].Journal of Clinical Microbiology,2004,42( 12) :5885-5888．
[29] 邹明园 , 吴国球 . 抗原交叉反应对新型冠状病毒血清特异性抗体检测的影响 [J]. 临床检验杂志 ,2020,38(3):161-163. ZOU Mingyuan, WU Guoqiu. The effect of antigeniccross reaction on the detection of serum specificantibody of novel coronavirus [J]. Chinese Journal ofClinical Laboratory Science, 2020,38(3):161-163.
[30] 王远芳 , 邓杰伦 , 敖科萍 , 等 . 三种 SARS-CoV-2 抗体胶体金试剂诊断效能评价及假阳性控制策略探讨[J]. 中国呼吸与危重监护杂志 , 2020,19(3):214-218. WANG Yuanfang, DENG Jielun, AO Keping, et al.Evaluation of three colloidal gold reagents for SARSCoV-2-antibody and the control strategy of falsepositive[J]. Chinese Journal of Respiratory and CriticalCare Medicine, 2020, 19(3):214-218.
[31] ZHAO Juanjuan,YUAN Quan,WANG Haiyan, et al.Antibody responses to SARS-CoV-2 in patients withnovel coronavirus disease 2019[J]. Clinical InfectiousDiseases.2020,71(16):2027-2034.
[32] 张园，周泽奇，王志贤 , 等 . 新型冠状病毒核酸、抗原和抗体联合检测的临床价值讨论 [J]. 现代检验医学杂志，2020,35(3):99-102,109. ZHANG Yuan, ZHOU Zeqi, WANG Zhixian, et al.Discussion on the clinical value of combined detectionof SARS-CoV-2 nucleic acid，antigen and antibody[J].Journal of Modern Laboratory Medicine, 2020,35(5):99-102,109.
相似文献/References:
[1]童 伟,陈登奕,陈俊文,等.2019-nCoV 总抗体两种免疫学检测方法的应用评价[J].现代检验医学杂志,2020,35(02):80.[doi:10.3969/j.issn.1671-7414.2020.02.023]
TONG Wei,CHEN Deng-yi,CHEN Jun-wen,et al.Application Evaluation of Two Immunological Detection Methodsof 2019-nCoV Specific Antibodies[J].Journal of Modern Laboratory Medicine,2020,35(03):80.[doi:10.3969/j.issn.1671-7414.2020.02.023]
[2]陈泽衍,马 雯,张立俊,等.荧光免疫层析法检测全血2019-nCoV IgM 和IgG 抗体在新型冠状病毒肺炎诊断中的应用[J].现代检验医学杂志,2020,35(03):84.[doi:10.3969/j.issn.1671-7414.2020.03.021]
CHEN Ze-yan,MA Wen,ZHANG Li-jun,et al.Application of 2019-nCoV IgM and IgG Tests by Fluorescence
Immunochromatography in the Diagnosis of 2019-nCoV Infections[J].Journal of Modern Laboratory Medicine,2020,35(03):84.[doi:10.3969/j.issn.1671-7414.2020.03.021]
[3]胡纪文,王恩运,阚丽娟,等.三种化学发光法检测新型冠状病毒（SARS-CoV-2）抗体试剂盒的临床应用评价[J].现代检验医学杂志,2020,35(04):100.[doi:10.3969/j.issn.1671-7414.2020.04.025]
HU Ji-wen,WANG En-yun,KAN Li-juan,et al.Evaluation of Clinical Application of Three Chemiluminescence Detection Kits for Detection of Novel Coronavirus (SARS-CoV-2) Antibody[J].Journal of Modern Laboratory Medicine,2020,35(03):100.[doi:10.3969/j.issn.1671-7414.2020.04.025]
[4]朱旭阳,叶寒青,陈文亥,等.新型冠状病毒肺炎患者血清SARS-CoV-2 抗体的检测分析[J].现代检验医学杂志,2020,35(04):106.[doi:10.3969/j.issn.1671-7414.2020.04.026]
ZHU Xu-yang,YE Han-qing,CHEN Wen-hai,et al.Preliminary Analysis of Serum Antibodies Against SARS-CoV-2 in Patient with Coronavirus Disease 2019[J].Journal of Modern Laboratory Medicine,2020,35(03):106.[doi:10.3969/j.issn.1671-7414.2020.04.026]
[5]张园,周泽奇,王志贤,等.新型冠状病毒核酸、抗原和抗体联合检测的临床价值讨论[J].现代检验医学杂志,2020,35(05):99.[doi:10.3969/j.issn.1671-7414.2020.05.025]
ZHANG Yuan,ZHOU Ze-qi,WANG Zhi-xian,et al.Discussion on the Clinical Value of Combined Detection of SARS-CoV-2
Nucleic Acid，Antigen and Antibody[J].Journal of Modern Laboratory Medicine,2020,35(03):99.[doi:10.3969/j.issn.1671-7414.2020.05.025]
[6]陈赛,刘海艇,李铁,等.新型冠状病毒肺炎患者肝功能异常的相关临床分析[J].现代检验医学杂志,2020,35(05):103.[doi:10.3969/j.issn.1671-7414.2020.05.026]
CHEN Sai,LIU Hai-ting,LI Tie,et al.Clinical Analysis of Abnormal Liver Function in Patients with New
Coronavirus Pneumonia[J].Journal of Modern Laboratory Medicine,2020,35(03):103.[doi:10.3969/j.issn.1671-7414.2020.05.026]
[7]宗曾艳,熊丹,武薇,等.一种国产新型冠状病毒核酸检测试剂盒的性能验证[J].现代检验医学杂志,2020,35(05):113.[doi:10.3969/j.issn.1671-7414.2020.05.029]
ZONG Zeng-yang,XIONG Dan,WU Wei,et al.Performance Evaluation of A Domestic New Coronavirus Detection Kit[J].Journal of Modern Laboratory Medicine,2020,35(03):113.[doi:10.3969/j.issn.1671-7414.2020.05.029]
[8]孟凡萍,郝 坡.新型冠状病毒肺炎患者外周血淋巴细胞亚群的分析研究[J].现代检验医学杂志,2021,36(02):114.[doi:doi:10.3969/j.issn.1671-7414.2021.02.027]
MENG Fan-ping,HAO Po.Analysis of Peripheral Blood Lymphocyte Subsets in Patients with Novel Coronavirus Pneumonia[J].Journal of Modern Laboratory Medicine,2021,36(03):114.[doi:doi:10.3969/j.issn.1671-7414.2021.02.027]
[9]李 捷,刘 浩,韩建勋,等.量子点荧光免疫技术定量检测新型冠状病毒（SARS-CoV-2）S1抗原试剂盒的研制及性能评价[J].现代检验医学杂志,2022,37(02):148.[doi:10.3969/j.issn.1671-7414.2022.02.030]
LI Jie,LIU Hao,HAN Jian-xun,et al.Preparation and Performance Evaluation on Novel Corona Virus (SARS-CoV-2) S1 Antigen Quantum Dots Fluorescence Immunoassay Reagent[J].Journal of Modern Laboratory Medicine,2022,37(03):148.[doi:10.3969/j.issn.1671-7414.2022.02.030]
[10]吴永彬,李 凌.CRISPR/Cas系统在新型冠状病毒肺炎快速诊断中的应用[J].现代检验医学杂志,2022,37(03):1.[doi:10.3969/j.issn.1671-7414.2022.03.001]
WU Yong-bin,LI Ling.Application of CRISPR/Cas Systems in the Rapid Diagnosis of Coronavirus Disease 2019[J].Journal of Modern Laboratory Medicine,2022,37(03):1.[doi:10.3969/j.issn.1671-7414.2022.03.001]
[11]宁明哲,陶 月,陈雨欣,等.新型冠状病毒血清特异性抗体检测的假性问题分析和对策探讨[J].现代检验医学杂志,2020,35(06):129.[doi:doi:10.3969/j.issn.1671-7414.2020.06.031]
NING Ming-zhe,TAO Yue,CHEN Yu-xin,et al.SARS-CoV-2 Serological Antibody Testing: Problems of FalseDetections and the Solutions[J].Journal of Modern Laboratory Medicine,2020,35(03):129.[doi:doi:10.3969/j.issn.1671-7414.2020.06.031]